Cerus (CERS) News Today $1.65 -0.09 (-5.17%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.65 0.00 (-0.24%) As of 02/21/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Cerus Corporation’s 2024 Earnings Call Highlights Growth and ExpansionFebruary 21 at 8:20 PM | tipranks.comCerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial ResultsFebruary 21 at 8:13 PM | businesswire.comCerus (CERS) Receives a Buy from Cantor FitzgeraldFebruary 21 at 8:13 PM | markets.businessinsider.comCerus (NASDAQ:CERS) Releases Quarterly Earnings Results, Meets ExpectationsCerus (NASDAQ:CERS - Get Free Report) released its quarterly earnings data on Thursday. The biotechnology company reported ($0.01) EPS for the quarter, hitting analysts' consensus estimates of ($0.01). Cerus had a negative net margin of 11.19% and a negative return on equity of 37.90%.February 21 at 4:33 PM | marketbeat.comCerus targets 8%-11% revenue growth for 2025 with strong IFC demand and global expansionFebruary 21 at 4:29 AM | msn.comCerus reports Q4 EPS (1c), consensus (1c)February 21 at 4:29 AM | markets.businessinsider.comCerus backs FY25 product revenue view $194M-$200MFebruary 21 at 4:29 AM | markets.businessinsider.comCerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash FlowFebruary 21 at 2:52 AM | gurufocus.comQ4 2024 Cerus Corp Earnings Call TranscriptFebruary 21 at 12:41 AM | gurufocus.comCerus Corporation (CERS) Q4 2024 Earnings Call TranscriptFebruary 20 at 10:32 PM | seekingalpha.comCerus Corporation to Participate in the TD Cowen 45th Annual Health Care ConferenceFebruary 20 at 10:58 AM | finance.yahoo.comWhat To Expect From Cerus Corp (CERS) Q4 2024 EarningsFebruary 20 at 9:52 AM | gurufocus.comCerus Co. (NASDAQ:CERS) Shares Sold by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. decreased its holdings in Cerus Co. (NASDAQ:CERS - Free Report) by 8.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,461,684 shares of the biotechnoFebruary 13, 2025 | marketbeat.comCerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February ...February 7, 2025 | gurufocus.comCerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025February 7, 2025 | businesswire.comCerus Corp announces director will not seek re-electionFebruary 6, 2025 | msn.comCerus (NASDAQ:CERS) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?Cerus (NASDAQ:CERS) Share Price Passes Above 200-Day Moving Average - What's Next?January 31, 2025 | marketbeat.comCantor Fitzgerald Brokers Lift Earnings Estimates for CerusCerus Co. (NASDAQ:CERS - Free Report) - Equities research analysts at Cantor Fitzgerald raised their FY2024 earnings per share estimates for Cerus in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now expects that the biotechnology company will post earnings per shaJanuary 23, 2025 | marketbeat.comShort Interest in Cerus Co. (NASDAQ:CERS) Grows By 16.2%Cerus Co. (NASDAQ:CERS - Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 7,800,000 shares, an increase of 16.2% from the December 15th total of 6,710,000 shares. Based on an average daily volume of 1,590,000 shares, the short-interest ratio is presently 4.9 days.January 19, 2025 | marketbeat.comTD Cowen Remains a Buy on Cerus (CERS)January 14, 2025 | markets.businessinsider.comCerus raises FY24 revenue view to $180.3M from $177M-$179M, consensus $186.18MJanuary 14, 2025 | markets.businessinsider.comPositive Growth Outlook and Undervaluation Support Buy Rating for CerusJanuary 14, 2025 | markets.businessinsider.comCerus expects prelim FY 2024 product revenue to be $180.3MJanuary 13, 2025 | msn.comCerus Reports 15% Increase In Full Year Preliminary Product RevenueJanuary 13, 2025 | markets.businessinsider.comCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business UpdateJanuary 13, 2025 | businesswire.comCatherine Wood Reduces Stake in Cerus Corp: Analyzing the ImplicationsJanuary 10, 2025 | gurufocus.comCerus And 2 Other US Penny Stocks With Promising PotentialJanuary 7, 2025 | finance.yahoo.comInsider Sell Alert: Chrystal Jensen Sells 16,667 Shares of Cerus Corp (CERS)December 16, 2024 | gurufocus.comCerus Co. (NASDAQ:CERS) Director Sells $35,600.00 in StockCerus Co. (NASDAQ:CERS - Get Free Report) Director Eric Bjerkholt sold 20,000 shares of Cerus stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $1.78, for a total value of $35,600.00. Following the sale, the director now directly owns 162,133 shares of the company's stock, valued at approximately $288,596.74. This trade represents a 10.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.December 16, 2024 | marketbeat.comSenvest Management LLC Has $10.45 Million Stock Position in Cerus Co. (NASDAQ:CERS)Senvest Management LLC reduced its holdings in Cerus Co. (NASDAQ:CERS - Free Report) by 17.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,006,376 shares of the biotechnology company's stoNovember 24, 2024 | marketbeat.comCerus Corp (CU2.SG)November 24, 2024 | finance.yahoo.comSumitomo Mitsui Trust Group Inc. Sells 457,953 Shares of Cerus Co. (NASDAQ:CERS)Sumitomo Mitsui Trust Group Inc. trimmed its holdings in shares of Cerus Co. (NASDAQ:CERS - Free Report) by 6.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,040,287 shares of the biotechnology company's stock after selling 457,November 18, 2024 | marketbeat.comShort Interest in Cerus Co. (NASDAQ:CERS) Rises By 7.9%Cerus Co. (NASDAQ:CERS - Get Free Report) saw a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 7,930,000 shares, a growth of 7.9% from the October 15th total of 7,350,000 shares. Based on an average daily volume of 1,400,000 shares, the days-to-cover ratio is presently 5.7 days.November 17, 2024 | marketbeat.comGSA Capital Partners LLP Has $1.67 Million Stock Holdings in Cerus Co. (NASDAQ:CERS)GSA Capital Partners LLP lessened its position in Cerus Co. (NASDAQ:CERS - Free Report) by 34.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 959,978 shares of the biotechnology company's stock after selling 505,044 shares during theNovember 13, 2024 | marketbeat.comCerus Co. (NASDAQ:CERS) Shares Sold by ARK Investment Management LLCARK Investment Management LLC reduced its stake in shares of Cerus Co. (NASDAQ:CERS - Free Report) by 8.4% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 18,225,031 shares of the biotechnology company's stock after selling 1,675,153 shares during the periodNovember 8, 2024 | marketbeat.com3 High-Potential Small-Cap Stocks Wall Street LovesNovember 4, 2024 | stocknews.comCerus Corporation Announces Third Quarter 2024 Financial ResultsNovember 1, 2024 | businesswire.comCerus Corporation: Strong Market Position and Strategic Advancements Drive Buy RatingNovember 1, 2024 | markets.businessinsider.comCerus Corp (CERS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...November 1, 2024 | finance.yahoo.comCantor Fitzgerald Reaffirms Their Buy Rating on Cerus (CERS)November 1, 2024 | markets.businessinsider.comCerus Q3 2024 Earnings PreviewOctober 29, 2024 | msn.comCathie Wood’s ARK Investment buys 193K shares of Cerus todayOctober 24, 2024 | markets.businessinsider.comCerus (CERS) Scheduled to Post Quarterly Earnings on WednesdayCerus (NASDAQ:CERS) will be releasing earnings after the market closes on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=637281)October 23, 2024 | marketbeat.comCathie Wood’s ARK Investment buys 412K shares of Cerus todayOctober 23, 2024 | msn.comCerus (NASDAQ:CERS) Stock, Option ChainOctober 22, 2024 | benzinga.comCathie Wood’s ARK Investment buys 255K shares of Cerus todayOctober 22, 2024 | markets.businessinsider.comCerus price target lowered to $3 from $6 at StifelOctober 18, 2024 | finance.yahoo.comStifel Nicolaus Reaffirms Their Buy Rating on Cerus (CERS)October 17, 2024 | markets.businessinsider.comCerus (CERS) Gets a Buy from Craig-HallumOctober 17, 2024 | markets.businessinsider.comOptimistic Future for Cerus: Buy Rating Despite EU Setback, Support from BARDA Boosts US ProspectsOctober 17, 2024 | markets.businessinsider.com Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address CERS Media Mentions By Week CERS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERS News Sentiment▼0.440.60▲Average Medical News Sentiment CERS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERS Articles This Week▼142▲CERS Articles Average Week Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies STAA News Today OSUR News Today ANIK News Today UTMD News Today COO News Today WST News Today ALGN News Today MMSI News Today ICUI News Today XRAY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.